| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |